Fertility and Sterility
Volume 89, Issue 5 , Pages 1209-1212 , May 2008

Anastrozole or letrozole for ovulation induction in clomiphene-resistant women with polycystic ovarian syndrome: a prospective randomized trial

  • Ahmed Badawy, M.D.

      Affiliations

    • Department of Obstetrics & Gynecology, Mansoura University, Mansoura, Egypt
    • Corresponding Author InformationReprint requests: Ahmed Badawy, M.D., M.R.C.O.G., Department of Obstetrics & Gynecology, Mansoura University Hospitals, Mansoura, Egypt (FAX: 20502303939).
    • ,
  • Abeer Mosbah, M.D.

      Affiliations

    • Department of Clinical Pathology, Mansoura University, Mansoura, Egypt
    • ,
  • Magda Shady, M.D.

      Affiliations

    • Department of Radiology, Mansoura University, Mansoura, Egypt

Received 12 March 2007 ,Revised 27 April 2007 ,Accepted 2 May 2007.

References 

  1. Kovacs G, Wood C. The current status of polycystic ovary syndrome. Aust NZ J Obstet Gynecol. 2001;41:65–68
  2. Guzick D. Polycystic ovary syndrome. Symptomatology, pathophysiology and epidemiology. Am J Obstet Gynecol. 1998;179:89–93
  3. Franks S, Adams J, Mason H, Polson D. Ovulatory disorders in women with polycystic ovary syndrome. Clin Obstet Gynecol. 1985;12:605–632
  4. Kistner RW. Induction of ovulation with clomiphene citrate (clomide). Obstet Gynecol Survey. 1965;20:873–900
  5. Badawy A, State O, Abdelgawad S. N-Acetyl cysteine and clomiphene citrate for induction of ovulation in polycystic ovary syndrome: a cross-over trial. Acta Obstet et Gynecol. 2007;86:218–222
  6. Badawy A, El Nashar A, El Totongy M. Clomiphene citrate plus N-acetyl cysteine versus clomiphene citrate for augmenting ovulation in the management of unexplained infertility: a randomized double-blind controlled trial. Fertil Steril. 2006;86:647–670
  7. Brodie AM, Njar VC. Aromatase inhibitors and breast cancer. Semin Oncol. 1996;23:10–20
  8. PDR Staff . Anastrozole. Physicians Desk Reference PDR. 55th ed.. Montvale, NJ: Medical Economics Company Inc; 2001;662–85
  9. The Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group . Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil Steril. 2004;81:19–25
  10. Vendola K, Zhou J, Wang J. Androgens promote oocyte insulin-like growth factor I expression and initiation of follicle development in the primate ovary. Biol Reprod. 1999;61:353–357
  11. Weil S, Vendola K, Zhou J, Bondy CA. Androgen and follicle-stimulating hormone interactions in primate ovarian follicle development. J Clin Endocrinol Metab. 1999;84:2951–2956
  12. Mitwally M, Casper R. Use of aromatase inhibitor for ovulation induction in patients with an inadequate response to clomiphene citrate. Fertil Steril. 2001;75:305–309
  13. Bayar U, Tanrıverdi HA, Aykut B, Ayoğlu F, Özcan O, Erdal K. Letrozole vs. clomiphene citrate in patients with ovulatory infertility. Fertil Steril. 2006;85:1045–1048
  14. Al-Fozan H, Al-Khadouri M, Tang Seang L, Tulandi T. A randomized trial of letrozole versus clomiphene citrate in women undergoing superovulation. Fertil Steril. 2004;82:1561–1563
  15. Mitwally M, Casper R. Aromatase inhibition improves ovarian response to follicle-stimulating hormone in poor responders. Fertil Steril. 2002;77:776–780
  16. Healey S, Tan SL, Tulandi T, Biljan M. Effects of letrozole on superovulation with gonadotropins in women undergoing intrauterine insemination. Fertil Steril. 2003;80:1325–1329
  17. Byung CJ, Seung YK, Chang SS, Ki CK, Won DL, et al. Use of letrozole versus clomiphene citrate combined with gonadotropins in intrauterine insemination cycles: a pilot study. Fertil Steril. 2006;85:1774–1777
  18. Geisler J, Haynes B, Anker G, Dowsett M, Lonning PE. Influence of etrozole and anastrozole on total body aromatization and plasma estrogen levels in postmenopausal breast cancer patients evaluated in a randomized, cross-over study. J Clin Oncol. 2002;2:751–757
  19. Badawy A, Metwally M, Fawzy M. Randomized controlled trial of three doses of letrozole for ovulation induction in patients with unexplained infertility. RBM Online. 2007;14:559–562
  20. Cortinez I, De Carvalho D, Vantman F, Gabler G, Iniguez R, Vega M. Hormonal profile and endometrial morphology in letrozole-controlled ovarian hyperstimulation in ovulatory infertile patients. Fertil Steril. 2005;83:110–115
  21. Al-Omari WR, Sulaiman W, Al-Hadithi N. Comparison of two aromatase inhibitors in women with clomiphene-resistant polycystic ovary syndrome. Intern J Gynecol Obstet. 2004;85:289–291
  22. Biljan MM, Hemmings R, Brassard N. The outcome of 150 babies following the treatment with letrozole or letrozole and gonadotropins. Fertil Steril. 2005;84(Suppl 1):O-231
  23. Fontana PG, Leclerc JM. Contraindication of Femara (letrozole) in premenopausal women. http://www.ca.novartis.com/downloads/en/letters/femara-hcp-e-17-1105.pdf
  24. Tulandi T, Martin J, Al-Fadhli R, Kabli N, Forman R, Hitkari J, et al. Congenital malformations among 911 newborns conceived after infertility treatment with letrozole or clomiphene citrate. Fertil Steril. 2006;85:1761–1765
  25. Anastrozole monograph. AstraZeneka data on file, International edition, September 2002.

PII: S0015-0282(07)01038-2

doi: 10.1016/j.fertnstert.2007.05.010

Fertility and Sterility
Volume 89, Issue 5 , Pages 1209-1212 , May 2008

Article Tools